Lucemyra (lofexidine tablets – US WorldMeds, generic) — Cigna

Initial criteria

• Lofexidine is being used to facilitate abrupt opioid discontinuation; AND
• Patient has a history of clonidine use (e.g., patches, tablets) and experienced unacceptable toxicity and/or inadequate efficacy

Approval duration

2 weeks